Diabetic microangiopathy is a major cause of disability and long-term mortality in patients with type 1 diabetes mellitus (T1DM). As an essential micronutrient in the human body, magnesium participates in a variety of enzymatic reactions and plays a vital role in maintaining intracellular homeostasis, bone metabolism, neuromuscular function, as well as regulating inflammation and coagulation. […]
Tag: T1DM
Non-Insulin Therapeutic Agents for T1DM
During the 2025 Peking University Diabetes Forum & Coastal Long Bridge Symposium on Metabolic Diseases,Professor Gu Nan from the Department of Endocrinology, Peking University First Hospital, delivered a report on the current application of non‑insulin agents, providing clinicians with scientifically sound and practically valuable references.
Residual Islet Function Still Exists in Patients with Long-Duration T1DM
During the 2025 Peking University Diabetes Forum and Coastal Long Bridge Symposium on Metabolic Diseases,Professor Gu Nan from the Department of Endocrinology, Peking University First Hospital, delivered a report on the current status and challenges of insulin therapy for type 1 diabetes mellitus (T1DM).Insulin replacement therapy is the core treatment for T1DM, but its clinical […]
Clinical Staging and Three-Tier Prevention Strategies for T1DM
For a long time, insulin replacement therapy has been the cornerstone of treatment for type 1 diabetes mellitus (T1DM). However, clinical practice has long been challenged by issues such as the risk of hypoglycemia, weight gain, and aggravated insulin resistance. With in-depth exploration of disease mechanisms, the preservation of residual β‑cell function and adjuvant non‑insulin […]